Skip to main content

Table 2 Antimicrobial resistance of K. pneumoniae ESBL-producing isolates

From: High clonal diversity of ESBL-producing Klebsiella pneumoniae isolates from clinical samples in a non-outbreak situation. A cohort study

Antibiotic Community- acquired (N = 5) Healthcare- related N = 24 Hospital- acquired infection (N = 31) Total
Amoxicillin-clavulanic acid 3/5 21/24 31/31 55/60
Amikacin 0/5 2/24 1/27 3/57
Cefepime 5/5 24/24 31/31 60/60
Cefuroxime 5/5 24/24 31/31 60/60
Cefotaxime 5/5 24/24 31/31 60/60
Ceftazidime 5/5 24/24 31/31 60/60
Ciprofloxacin 3/5 21/24 31/31 55/60
Ertapenem 0/5 0/24 0/31 0 / 60
Gentamicin 1/5 13/24 14/31 28 /60
Imipenem 0/5 0/24 0 /31 0 /60
Piperacillin/tazobactam 2/5 12/24 20/31 34/60
Trimethoprim/sulfamethoxazole 3/5 21/24 29/31 53/60